Literature DB >> 2714734

Effect of vasodilators on hepatic microcirculation in cirrhosis: a study in the isolated perfused rat liver.

P Marteau1, F Ballet, O Chazouillères, Y Chrétien, C Rey, D Petit, R Poupon.   

Abstract

We studied the effects of a series of vasodilators on intrahepatic vascular resistance of isolated perfused cirrhotic rat livers in basal conditions and during norepinephrine-induced vasoconstriction. Cirrhosis was induced by repeated intraperitoneal injections of carbon tetrachloride. The vasodilators were a nonselective beta-adrenergic antagonist (propranolol), an alpha 1-adrenergic antagonist (prazosin), a nonselective beta-adrenergic agonist (isoproterenol), an alpha 2-agonist (clonidine), nitrovasodilators (nitroglycerin and nitroprusside), calcium channel blockers (verapamil, diltiazem, nifedipine), papaverine, diazoxide and pentoxifylline. In basal conditions, isoproterenol, nitroglycerin, papaverine, pentoxifylline and nitroprusside demonstrated significant vasodilatory activity. However, the response was weak and isoproterenol was the only drug active in the therapeutic range of concentrations. Propranolol, prazosin, verapamil, diltiazem, nifedipine and diazoxide were ineffective. Prazosin, papaverine and pentoxifylline reduced norepinephrine-induced vasoconstriction, whereas isoproterenol, clonidine and propranolol were ineffective. We conclude that several vasodilators can reduce resistance in the cirrhotic rat liver, but their potency is low and few are effective at therapeutic concentrations. Furthermore, their activity may be blunted when resistance is increased by norepinephrine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2714734     DOI: 10.1002/hep.1840090605

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  Reversal of the vasoconstrictor step of hyperacute xenogeneic rejection of the liver by endothelin antagonists.

Authors:  B Zhang; L Wen; A Gomola; P P Massault; B Cherruau; D Houssin; B Weill; Y Calmus
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Hepatic venous dysregulation contributes to blood volume pooling in cirrhotic rats.

Authors:  Y Li; H Liu; S A Gaskari; D-M McCafferty; S S Lee
Journal:  Gut       Date:  2006-01-09       Impact factor: 23.059

3.  In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats.

Authors:  M Van de Casteele; A Omasta; S Janssens; T Roskams; V Desmet; F Nevens; J Fevery
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 4.  Mechanisms and consequences of portal hypertension.

Authors:  P M MacMathuna
Journal:  Drugs       Date:  1992       Impact factor: 9.546

5.  Effect of early bosentan administration on the development of esophageal varices in cirrhotic rats: experimental study in Wistar rats.

Authors:  Savas Rafailidis; Konstantinos Ballas; Kyriakos Psarras; Theodoros Pavlidis; Eleni Emoniotou; Rodoula Papamichali; Georges Kalodimos; Georges Marakis; Athanassios Sakadamis; Georges Koukoulis
Journal:  J Gastroenterol       Date:  2008-11-18       Impact factor: 7.527

6.  Hemodynamic effects of one week of carvedilol administration on cirrhotic rats.

Authors:  Han-Chieh Lin; Yi-Tsau Huang; Hung-Chi Wei; Ying-Ying Yang; Tzung-Yan Lee; Ying-Wen Wang; Ming-Chih Hou; Shou-Dong Lee
Journal:  J Gastroenterol       Date:  2006-04       Impact factor: 6.772

Review 7.  Hepatic circulation: potential for therapeutic intervention.

Authors:  F Ballet
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.